Unitree Robotics Sets 150.8 Yuan IPO Price, Raising the Valuation Test

Unitree Robotics has priced its Shanghai initial public offering at 150.8 yuan per share, turning years of robot demonstrations into a public valuation test. The offer values the company at approximately 61 billion yuan after the issuance. That is substantially above the valuation implied when Unitree first filed to raise capital.

The price was reported on August 7, 2026, after institutional investors participated in the offering process. It moves Unitree closer to becoming mainland China’s first publicly traded company centered on humanoid robots. The listing also gives investors a rare financial benchmark for an industry dominated by private companies and long development timelines.

The important conflict is not Unitree against another robot manufacturer. It is Unitree’s public valuation against the commercial evidence available today. The company delivered rapid revenue growth and reported a profit in 2025. However, its first-quarter adjusted profit fell sharply as research, sales, and competitive expenses increased.

That tension makes the IPO more than a financing event. Unitree is asking public investors to price a future market for general-purpose robots before that market has reached broad commercial adoption.

What Unitree’s 150.8 Yuan Offer Changes

The offer price replaces an estimated valuation with a public-market commitment.

Unitree’s IPO application was accepted by the Shanghai Stock Exchange on March 20, 2026. The exchange’s listing committee approved the application on June 1, and Chinese regulators approved its registration in early July. Those steps established that Unitree could proceed, but they did not determine what investors would pay.

The August pricing decision fills that gap. Multiplying the offer price by Unitree’s expected post-issuance share count produces a valuation near 61 billion yuan. The initial plan had implied a valuation closer to 42 billion yuan, based on the proposed capital raise and minimum public float.

That difference matters because an IPO price represents more than an estimate from a private funding round. Institutional investors submit demand during book building, while the issuer and underwriter use those indications to set the final offer. The result becomes the starting reference for public trading.

Unitree originally planned to issue at least 40.4464 million new shares, representing no less than 10 percent of its post-offering equity. Its IPO filing identified four destinations for the proceeds: robot model research, robot-body development, new products, and manufacturing capacity.

At the offer price, gross proceeds would exceed the amount proposed in the original fundraising plan. The final net amount will depend on the confirmed share allocation and issuance expenses. Still, the pricing gives Unitree considerably more capital for product development and production expansion.

The sequence also establishes the underlying event date. The company passed its listing review on June 1 and received registration approval in early July. The 150.8 yuan figure belongs to the offering stage reported on August 7, not to either earlier regulatory milestone.

That distinction is important because Chinese technology listings pass through several announcements. Approval to list does not equal a completed IPO. Pricing establishes the economic terms, while subscriptions, allocations, and the first trading session determine how the market receives them.

Unitree has therefore crossed from regulatory eligibility into market price discovery. The next question is whether public trading supports the offer valuation after the initial scarcity and excitement fade.

The Valuation Is Pricing More Than Current Robot Sales

Investors are valuing Unitree as an early platform for embodied AI, not only as a hardware manufacturer.

Embodied AI refers to artificial intelligence that perceives and acts through a physical machine. In Unitree’s case, the machines include humanoid robots, four-legged robots, and related components. The ambition is to connect mechanical design with models that help robots understand environments and complete tasks.

Unitree reported approximately 1.7 billion yuan in 2025 revenue. Its adjusted profit, which excludes non-recurring items, reached about 591 million yuan. Those results distinguish it from many humanoid robot developers that remain unprofitable.

The company’s profitability gives investors a foundation for valuation. It sells real machines today, including quadruped systems used in research, inspection, education, and demonstrations. Its humanoid products have also gained attention because their mobility can be displayed clearly in public performances.

However, current sales alone do not explain a valuation near 61 billion yuan. The offer values Unitree at roughly 36 times its reported 2025 revenue. The exact ratio depends on the final post-offering equity structure and accounting period used.

This multiple reflects expectations that Unitree can expand beyond specialized customers. The company must sell more units, support more useful tasks, and preserve margins while competitors introduce their own machines. Investors are effectively paying for progress that has not yet appeared fully in reported revenue.

Unitree’s original fundraising target provides another clue. According to its prospectus, almost half of the planned proceeds were directed toward intelligent robot model development. That allocation places the robot’s control and learning systems near the center of the company’s growth strategy.

Hardware can become easier to compare as components standardize. Software, training data, control models, and deployment experience can create more durable differentiation. Unitree’s valuation suggests investors expect it to combine both layers rather than remain a seller of athletic machines.

The company also enters the market with a recognizable brand. Videos of Unitree robots running, balancing, dancing, and performing coordinated movements have traveled widely online. That visibility reduces the cost of explaining what the company builds, but attention does not guarantee durable demand.

A robot performing onstage proves mobility under a controlled plan. It does not prove that the same machine can work safely across changing homes, factories, or public spaces. Commercial buyers need predictable uptime, service support, task completion, and an economic return.

Unitree’s valuation therefore includes two separate bets. One is that the company can keep selling increasingly capable robots. The other is that embodied AI will convert those machines from research products into repeatable labor and service platforms.

Public trading will expose both assumptions to continuous review. Each shipment update, margin change, product release, and customer deployment can now influence how investors value the company.

Profitability Gives Unitree an Edge, but the Trend Is Weakening

Unitree reached the IPO with profits, yet its latest results show how expensive the next stage may become.

The company’s 2025 performance created a favorable comparison with publicly traded robotics businesses. Unitree reported 1.7 billion yuan in revenue and 591 million yuan in adjusted profit. Hong Kong-listed UBTech reported about 2 billion yuan in revenue but recorded a net loss of roughly 700 million yuan.

That comparison does not make the businesses identical. UBTech serves a different product mix and has invested heavily in industrial deployments. Still, the figures show why Unitree’s IPO attracted attention: it reached public markets with meaningful sales and positive earnings.

The pressure appeared in the first quarter of 2026. Revenue increased more than 68 percent from a year earlier to 422.8 million yuan. Adjusted profit fell more than 52 percent to 40.3 million yuan, from 84.8 million yuan in the prior-year period.

Unitree attributed the decline to higher research, development, and sales spending. It also cited stronger competition and a more difficult comparison after rapid growth in 2025. The quarterly results show that revenue growth and profit growth are already moving in opposite directions.

That divergence is the central financial risk behind the offering. Building more robots can increase revenue while reducing profit if discounts, component costs, marketing, and engineering expenses rise faster. A fast-growing market does not automatically produce attractive economics.

Unitree faces pressure on several fronts. Chinese robotics companies are launching more humanoid products, while established industrial automation vendors bring deeper customer relationships. Tesla, Figure, AgiBot, UBTech, and other developers are also pursuing machines that can perform useful physical work.

These competitors follow different strategies. Tesla can connect Optimus development with manufacturing operations and large-scale capital spending. Figure has emphasized partnerships and general-purpose autonomy. UBTech is pushing deployments in industrial environments, while AgiBot is building a broad product range and manufacturing presence in China.

Unitree’s advantage lies partly in compact mechanical systems and comparatively accessible products. Its quadruped robots created an installed base among laboratories and developers before humanoid robots became the industry’s main focus. That experience can support faster iteration and component reuse.

Yet accessible hardware can intensify competition. Lower entry prices allow more organizations to experiment, but they can also limit margins. If rivals match Unitree’s movement capabilities, customers will compare software, reliability, maintenance, and task performance more closely.

The IPO proceeds can fund the response. Unitree can invest in control models, new robot bodies, manufacturing equipment, and commercial support. More capital also allows the company to run longer development programs before each project produces revenue.

Capital does not remove the underlying tradeoff. Spending aggressively can defend technical leadership while weakening near-term earnings. Protecting profit can leave the company vulnerable in a market where competitors are still financing ambitious development programs.

The 150.8 yuan offer price assumes Unitree can manage both demands. Its future reports must show whether higher spending creates stronger products and repeatable orders, rather than only more demonstrations.

Public Markets Are Now Pricing the Humanoid Robot Race

Unitree’s listing creates a valuation reference that private robotics companies previously lacked.

Most prominent humanoid robot developers remain privately held. Their valuations emerge during occasional funding rounds, often with limited financial disclosure. That makes it difficult to compare investor enthusiasm with actual revenue, margins, and cash requirements.

A listed Unitree changes that structure. Its share price will produce a visible valuation every trading day. Competitors, suppliers, venture investors, and customers can compare that valuation with the company’s reported performance.

Before pricing, Unitree’s planned fundraising amount implied a valuation around 42 billion yuan. Analysts already viewed that figure as a benchmark for China’s embodied AI sector. The final offer pushes the reference closer to 61 billion yuan before secondary-market trading begins.

The valuation benchmark can affect companies beyond Unitree. Private robotics developers may use it when negotiating new funding. Listed suppliers may attract investors seeking indirect exposure. Other robot manufacturers preparing IPOs will face comparisons with Unitree’s growth and profitability.

That creates pressure for competitors to disclose commercial evidence. A product video can establish technical interest, but public investors eventually ask how many machines were delivered, what customers paid, and whether deployments generated repeat orders.

The listing also sharpens the comparison between specialized robot makers and diversified technology companies. Unitree depends directly on robot sales and related development. Tesla, Xiaomi, and XPeng can fund robotics work using revenue and infrastructure from larger businesses.

A focused company can move quickly because robotics receives management attention and capital. It also carries concentrated risk. Delays in adoption, component problems, or safety incidents would affect a larger share of Unitree’s business than they would at a diversified manufacturer.

Suppliers face a related calculation. Growing robot production could increase demand for motors, reducers, sensors, batteries, processors, and lidar. Yet prototype demand does not always become high-volume procurement, and manufacturers can redesign components between generations.

Customers will watch the listing for a different reason. Financial strength matters when purchasing machines that require years of software support and replacement parts. The IPO gives Unitree capital, greater disclosure obligations, and more public scrutiny.

Public status can also make security and geopolitical questions more visible. Unitree sells internationally, and advanced mobile robots can attract concerns about data collection, remote access, and dual-use applications. Those questions can influence procurement even when the underlying machines have civilian purposes.

The company’s domestic listing limits direct access for many international investors. However, the valuation can still shape global expectations. A strong debut would support the argument that humanoid robotics deserves premium technology multiples. A weak debut would encourage more skepticism toward private valuations.

Neither result would settle the technology race. Share prices can reflect liquidity, market mood, and limited supply as much as commercial progress. Unitree’s market capitalization will be useful only when read alongside operating results.

The lasting benchmark will come from revenue quality, margins, customer concentration, and deployment outcomes. The IPO creates a number, but future disclosures will determine what that number actually measures.

What the 150.8 Yuan Price Does Not Prove

A successful offering does not establish that general-purpose humanoid robots have found a scalable market.

Unitree has demonstrated impressive movement and reported strong financial growth. Those facts support interest in the company. They do not resolve the technical and commercial limits facing humanoid robots.

A controlled performance rewards repeatable movement. Commercial environments demand adaptation. A robot may encounter shifting objects, uneven surfaces, people who behave unpredictably, or tools positioned differently from its training examples.

Reliability becomes more important as the use case moves closer to real work. Buyers need to know how long a robot can operate, how often a human must intervene, and how quickly damaged components can be replaced. These measures rarely appear in viral videos.

The economics are equally important. A customer compares the full deployment cost with the value of completed tasks. That calculation includes hardware, software, integration, training, supervision, maintenance, energy, and downtime.

Unitree warned in its filings that slower commercial adoption or weaker demand in the robot rental market could pressure growth and margins. The warning is material because rentals and demonstrations can create revenue without proving permanent operational demand.

Research and education customers are useful early adopters. They tolerate experimentation and can help developers improve systems. However, their purchasing patterns differ from industrial fleets that require consistent performance and clear returns.

The first-quarter profit decline makes this uncertainty more immediate. Unitree increased revenue while spending more on development and sales. If those expenses produce stronger products and durable customers, the decline may reflect investment ahead of growth.

The less favorable outcome is that competition forces continuous spending and lower margins. Robot manufacturers may need frequent redesigns, customer-specific integration, and extensive support. In that scenario, revenue can grow without producing the operating leverage expected from a technology platform.

The IPO price also does not prove a stable secondary-market valuation. Initial offerings can attract concentrated demand because available shares are limited. Early trading can amplify that imbalance before analysts receive several quarters of public results.

Investors should avoid treating the offer multiple as an industry standard without context. UBTech, industrial robot manufacturers, software companies, and diversified automakers have different revenue models. Comparing market capitalizations without those differences can mislead.

Shipment counts require similar caution. A delivered robot can represent a research sale, a rental unit, a demonstration machine, or a production deployment. The number becomes more meaningful when paired with customer type, utilization, repeat orders, and gross margin.

Technical capability also needs task-level evidence. A robot that can walk and recover from a push has solved difficult engineering problems. It has not necessarily shown that it can perform economically useful work for hours without supervision.

Unitree’s offer is therefore evidence of investor demand, regulatory progress, and financial credibility. It is not proof that humanoid robots have crossed from early products into a mature labor market.

That verification gap is not unique to Unitree. It defines the entire sector. The company is simply becoming one of the first major developers required to report its progress in public.

Three Signals That Will Decide Whether the IPO Valuation Holds

The next test comes from operating evidence, not another performance video.

The first signal is Unitree’s first set of results as a public company. Investors should focus on revenue growth, adjusted profit, gross margin, research spending, and operating cash flow. These figures will show whether the first-quarter profit decline was temporary or part of a longer investment cycle.

Management’s explanation will matter as much as the headline numbers. Higher research spending can support future products, but sales expenses should eventually translate into orders. Cash flow can reveal whether reported earnings are converting into money available for operations.

A rebound in adjusted profit alongside continued revenue growth would strengthen the offer valuation. Another sharp decline would increase pressure on Unitree to explain when its investments will produce returns.

The second signal is the quality of commercial deployments. Unitree needs examples where customers use robots repeatedly for inspection, manufacturing, logistics, services, or research workflows. Those examples should disclose enough information to distinguish daily operations from short trials.

Repeat orders would be particularly valuable. A customer buying additional units after an initial deployment suggests that the machines created measurable value. Longer operating periods with limited human intervention would provide stronger technical evidence.

The company does not need to solve every household task immediately. Narrow, repeatable deployments can support a large business if they address expensive or hazardous work. The key is whether Unitree can turn mechanical capability into reliable task completion.

The third signal is the competitive response. UBTech, AgiBot, Tesla, Figure, and other developers will continue introducing products and partnerships. Their progress can affect Unitree even if their machines target different initial markets.

A competitor that delivers better autonomy, longer operation, or lower deployment costs could weaken Unitree’s position. Conversely, broad industry progress may expand customer interest and supplier capacity, helping several manufacturers at once.

Regulatory and procurement responses belong inside this signal. More security restrictions could limit certain international markets, while government or industrial purchasing programs could accelerate domestic deployments. Public disclosure will make these effects easier to track.

Unitree reached its listing review unusually quickly. Its application was accepted in March, approved by the exchange in June, and cleared by regulators in July. The review approval reflected support for a profitable technology manufacturer entering public markets.

Pricing on August 7 completed the next major step. It also raised the burden of proof. A valuation near 61 billion yuan demands more than continued interest in humanoid robots.

Unitree must show that its revenue can scale without persistent margin compression. It must demonstrate that customers use its machines beyond exhibitions and short rentals. It must also keep pace with rivals that have access to substantial capital and engineering talent.

For developers and enterprise buyers, the most useful response is to ignore the daily share-price drama and watch deployment evidence. Track which tasks robots complete, how much human supervision remains, and whether customers return for more units.

The offer price turns Unitree into a public experiment in embodied AI economics. The machines have already shown that they can move convincingly. The next phase must show that they can work consistently, create measurable value, and support the expectations now embedded in 150.8 yuan.